Effects of hyaluronan on nitric oxide levels and superoxide dismutase activities in synovial fluid in knee osteoarthritis

Clinical Rheumatology

Volumn 26, Issue 8, 2007, Pages 1306-1311

  Kalaci, Aydner ^a   Yilmaz, Rmazan H ^b   Aslan, Bahadr ^a   Sög̈üt, Sadik ^c   Yanat, Ahmet Nedim ^a   Uz, Efkan ^b  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

^b SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c KIRIKKALE UNIVERSITY   (Turkey)

Author keywords

Hyaluronan; Knee osteoarthritis; Nitric oxide; Superoxide dismutase; Synovial fluid

Indexed keywords

ANTIOXIDANT; COPPER ZINC SUPEROXIDE DISMUTASE; HYALURONIC ACID; MANGANESE SUPEROXIDE DISMUTASE; NITRIC OXIDE; SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; ASPIRATION; CHONDROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; FEMALE; HUMAN; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; MALE; MEDICAL DECISION MAKING; MEDICAL RESEARCH; PAIN ASSESSMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SCORING SYSTEM; SYNOVIAL FLUID; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; FEMALE; HUMANS; HYALURONIC ACID; MALE; MIDDLE AGED; NITRIC OXIDE; OSTEOARTHRITIS, KNEE; SUPEROXIDE DISMUTASE; SYNOVIAL FLUID;

EID: 34447117501     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0504-y     Document Type: Article

References (59)

1. Regan E, Flannelly J, Bowler R et al (2005) Extracellular superoxide dismutase and oxidant damage in osteoarthritis. Arthritis Rheum 52:3479-3491
2. Sandell LJ, Aigner T (2001) Articular cartilage and changes in arthritis. An introduction: Cell biology of osteoarthritis. Arthritis Res 3:107-113
3. Hashimoto S, Takahashi K, Amiel D et al (1998) Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis. Arthritis Rheum 41:1266-1274
4. Blanco FJ, Guitian R, Vazquez-Martul E et al (1998) Osteoarthritis chondrocytes die by apoptosis. A possible pathway for osteoarthritis pathology. Arthritis Rheum 41:284-289
5. Tanimoto K, Ohno S, Fujimoto K et al (2001) Proinflammatory cytokines regulate the gene expression of hyaluronic acid synthetase in cultured rabbit synovial membrane cells. Connect Tissue Res 42:187-195
6. Hashimoto S, Ochs RL, Komiya S, Lotz M (1998) Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis. Arthritis Rheum 41:1632-1638
7. Ghosh P, Cheras PA (2001) Vascular mechanisms in osteoarthritis. Best Pract Res Clin Rheumatol 15:693-709
8. Lotz M (2001) Cytokines in cartilage injury and repair. Clin Orthop Relat Res Suppl 391:108-115
9. Pelletier JP, Martel-Pelletier J, Abramson SB (2001) Osteoarthritis, an inflammatory disease: Potential implication for the selection of new therapeutic targets. Arthritis Rheum 44:1237-1247
10. Poole AR (1999) An introduction to the pathophysiology of osteoarthritis. Front Biosci 4:662-670
11. Tortorella MD, Malfait AM, Deccico C, Arner E (2001) The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation. Osteoarthritis Cartilage 9:539-552
12. Pelletier JP, Jovanovic D, Fernandes JC et al (1998) Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum 41:1275-1286
13. Hussain SP, Hofseth LJ, Harris CC (2003) Radical causes of cancer. Nat Rev Cancer 3:276-285
14. Amin AR, Abramson SB (1998) The role of nitric oxide in articular cartilage breakdown in osteoarthritis. Curr Opin Rheumatol 10:263-268
15. Clancy RM, Amin AR, Abramson SB (1998) The role of nitric oxide in inflammation and immunity. Arthritis Rheum 41:1141-1151
16. St Clair EW (1998) Nitric oxide - friend or foe in arthritis? J Rheumatol 25:1451-1453
17. Pelletier JP, Mineau F, Ranger P et al (1996) The increased synthesis of inducible nitric oxide inhibits IL-1ra synthesis by human articular chondrocytes: Possible role in osteoarthritic cartilage degradation. Osteoarthritis Cartilage 4:77-84
18. Haklar U, Yuksel M, Velioglu A et al (2002) Oxygen radicals and nitric oxide levels in chondral or meniscal lesions or both. Clin Orthop Relat Res 403:135-142
19. Ozgocmen S, Ardicoglu O, Erdogan H et al (2005) In vivo effect of celecoxib and tenoxicam on oxidant/anti-oxidant status of patients with knee osteoarthritis. Ann Clin Lab Sci 35:137-143
20. McInnes IB, Leung BP, Field M et al (1996) Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med 184:1519-1524
21. Karan A, Karan MA, Vural P et al (2003) Synovial fluid nitric oxide levels in patients with knee osteoarthritis. Clin Rheumatol 22:397-399
22. Lotz M (1999) The role of nitric oxide in articular cartilage damage. Rheum Dis Clin North Am 25:269-282
23. Tiku ML, Gupta S, Deshmukh DR (1999) Aggrecan degradation in chondrocytes is mediated by reactive oxygen species and protected by antioxidants. Free Radic Res 30:395-405
24. Mates JM, Perez-Gomez C, Nunez de Castro I (1999) Antioxidant enzymes and human diseases. Clin Biochem 32:595-603
25. Moreland LW (2003) Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: Mechanisms of action. Arthritis Res Ther 5:54-67
26. Altman R, Asch E, Bloch D et al (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29:1039-1049
27. Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494-502
28. Cortas NK, Wakid NW (1990) Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 36:1440-1443
29. Sun Y, Oberley LW, Li Y (1988) A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497-500
30. Lee MS, Trindade MC, Ikenoue T et al (2002) Effects of shear stress on nitric oxide and matrix protein gene expression in human osteoarthritic chondrocytes in vitro. J Orthop Res 20:556-561
31. Taskiran D, Stefanovic-Racic M, Georgescu H, Evans C (1994) Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1. Biochem Biophys Res Commun 200:142-148
32. Kobayashi K, Matsuzaka S, Yoshida Y et al (2004) The effects of intraarticularly injected sodium hyaluronate on levels of intact aggrecan and nitric oxide in the joint fluid of patients with knee osteoarthritis. Osteoarthritis Cartilage 12:536-542
33. Henrotin YE, Bruckner P, Pujol JP (2003) The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis Cartilage 11:747-755
34. Murrell GA, Jang D, Williams RJ (1995) Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun 206:15-21
35. Clancy R, Rediske J, Koehne C et al (2001) Activation of stress-activated protein kinase in osteoarthritic cartilage: Evidence for nitric oxide dependence. Osteoarthritis Cartilage 9:294-299
36. Blanco FJ, Lotz M (1995) IL-1-induced nitric oxide inhibits chondrocyte proliferation via PGE2. Exp Cell Res 218:319-325
37. Notoya K, Jovanovic DV, Reboul P et al (2000) The induction of cell death in human osteoarthritis chondrocytes by nitric oxide is related to the production of prostaglandin E2 via the induction of cyclooxygenase-2. J Immunol 165:3402-3410
38. Blanco FJ, Ochs RL, Schwarz H, Lotz M (1995) Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 146:75-85
39. Salvemini D, Mazzon E, Dugo L et al (2001) Amelioration of joint disease in a rat model of collagen-induced arthritis by M40403, a superoxide dismutase mimetic. Arthritis Rheum 44:2909-2921
40. Banford JC, Brown DH, Hazelton RA et al (1982) Serum copper and erythrocyte superoxide dismutase in rheumatoid arthritis. Ann Rheum Dis 41:458-462
41. Igari T, Kaneda H, Horiuchi S, Ono S (1982) A remarkable increase of superoxide dismutase activity in synovial fluid of patients with rheumatoid arthritis. Clin Orthop Relat Res 162:282-287
42. Cimen MY, Cimen OB, Kacmaz M et al (2000) Oxidant/antioxidant status of the erythrocytes from patients with rheumatoid arthritis. Clin Rheumatol 19:275-277
43. Sumii H, Inoue H, Onoue J et al (1996) Superoxide dismutase activity in arthropathy: Its role and measurement in the joints. Hiroshima J Med Sci 45:51-55
44. Mazzetti I, Grigolo B, Borzi RM et al (1996) Serum copper/zinc superoxide dismutase levels in patients with rheumatoid arthritis. Int J Clin Lab Res 26:245-249
45. Hoedt-Schmidt S, Schneider B, Kalbhen DA (1993) Histomorphological studies on the effect of recombinant human superoxide dismutase in biochemically induced osteoarthritis. Pharmacology 47:252-260
46. Sato H, Takahashi T, Ide H et al (1988) Antioxidant activity of synovial fluid, hyaluronic acid, and two subcomponents of hyaluronic acid. Synovial fluid scavenging effect is enhanced in rheumatoid arthritis patients. Arthritis Rheum 31:63-71
47. Fukuda K, Oh M, Asada S et al (2001) Sodium hyaluronate inhibits interleukin-1-evoked reactive oxygen species of bovine articular chondrocytes. Osteoarthritis Cartilage 9:390-392
48. Fukuda K, Takayama M, Ueno M et al (1997) Hyaluronic acid inhibits interleukin-1-induced superoxide anion in bovine chondrocytes. Inflamm Res 46:114-117
49. Kvam BJ, Fragonas E, Degrassi A et al (1995) Oxygen-derived free radical (ODFR) action on hyaluronan (HA), on two HA ester derivatives, and on the metabolism of articular chondrocytes. Exp Cell Res 218:79-86
50. Presti D, Scott JE (1994) Hyaluronan-mediated protective effect against cell damage caused by enzymatically produced hydroxyl (OH) radicals is dependent on hyaluronan molecular mass. Cell Biochem Funct 12:281-288
51. Takahashi K, Hashimoto S, Kubo T et al (2001) Hyaluronan suppressed nitric oxide production in the meniscus and synovium of rabbit osteoarthritis model. J Orthop Res 19:500-503
52. Kobayashi K, Mishima H, Harwood F et al (2002) The suppressive effect of hyaluronan on nitric oxide production and cell apoptosis in the central region of meniscus following partial meniscectomy. Iowa Orthop J 22:39-41
53. Takahashi K, Hashimoto S, Kubo T et al (2000) Effect of hyaluronan on chondrocyte apoptosis and nitric oxide production in experimentally induced osteoarthritis. J Rheumatol 27:1713-1720
54. Karatay S, Kiziltunc A, Yildirim K et al (2005) Effects of different hyaluronic acid products on synovial fluid NO levels in knee osteoarthritis. Clin Rheumatol 24:497-501
55. Tung JT, Venta PJ, Caron JP (2002) Inducible nitric oxide expression in equine articular chondrocytes: Effects of antiinflammatory compounds. Osteoarthritis Cartilage 10:5-12
56. Fraser JR, Kimpton WG, Pierscionek BK, Cahill RN (1993) The kinetics of hyaluronan in normal and acutely inflamed synovial joints: Observations with experimental arthritis in sheep. Semin Arthritis Rheum 22:9-17
57. Balazs EA, Denlinger JL (1993) Viscosupplementation: A new concept in the treatment of osteoarthritis. J Rheumatol Suppl 39:3-9
58. Stefanovic-Racic M, Taskiran D, Georgescu HI, Evans CH (1995) Modulation of chondrocyte proteoglycan synthesis by endogeneously produced nitric oxide. Inflamm Res 44:216-217
59. Murrell GA, Jang D, Williams RJ (1995) Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun 206:15-21